Publicaciones en colaboración con investigadores/as de Centro de Investigacion Biomedica en Red de Salud Mental (31)

2023

  1. GWAS Meta-Analysis of Suicide Attempt: Identification of 12 Genome-Wide Significant Loci and Implication of Genetic Risks for Specific Health Factors

    American Journal of Psychiatry

  2. Mendelian randomization analysis for attention deficit/hyperactivity disorder: studying a broad range of exposures and outcomes

    International journal of epidemiology, Vol. 52, Núm. 2, pp. 386-402

  3. Schizophrenia polygenic risk score in psychosis proneness

    European Archives of Psychiatry and Clinical Neuroscience, Vol. 273, Núm. 8, pp. 1665-1675

  4. Schizophrenia risk conferred by rare protein-truncating variants is conserved across diverse human populations

    Nature genetics, Vol. 55, Núm. 3, pp. 369-376

2022

  1. Completed suicide is associated with a higher polygenic burden for psychiatric disorders

    European Archives of Psychiatry and Clinical Neuroscience

  2. Mapping genomic loci implicates genes and synaptic biology in schizophrenia

    Nature, Vol. 604, Núm. 7906, pp. 502-508

2021

  1. Association of polygenic score for major depression with response to lithium in patients with bipolar disorder

    Molecular Psychiatry, Vol. 26, Núm. 6, pp. 2457-2470

  2. Correction to: Attention-deficit/hyperactivity disorder and lifetime cannabis use: genetic overlap and causality (Molecular Psychiatry, (2020), 25, 10, (2493-2503), 10.1038/s41380-018-0339-3)

    Molecular Psychiatry

  3. Genetic association study of childhood aggression across raters, instruments, and age

    Translational Psychiatry, Vol. 11, Núm. 1

  4. Genetic overlap and causality between substance use disorder and attention-deficit and hyperactivity disorder

    American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics, Vol. 186, Núm. 3, pp. 140-150

  5. Meta-analysis and systematic review of ADGRL3 (LPHN3) polymorphisms in ADHD susceptibility

    Molecular Psychiatry, Vol. 26, Núm. 6, pp. 2277-2285

2020

  1. Attention-deficit/hyperactivity disorder and lifetime cannabis use: genetic overlap and causality

    Molecular Psychiatry, Vol. 25, Núm. 10, pp. 2493-2503

2019

  1. Genome-wide analysis of emotional lability in adult attention deficit hyperactivity disorder (ADHD)

    European Neuropsychopharmacology, Vol. 29, Núm. 6, pp. 795-802

2018

  1. A personalized intervention to prevent depression in primary care: Cost-effectiveness study nested into a clustered randomized trial

    BMC Medicine, Vol. 16, Núm. 1

  2. Integrative genomic analysis of methylphenidate response in attention-deficit/hyperactivity disorder

    Scientific Reports, Vol. 8, Núm. 1

2016

  1. Intervention to prevent major depression in primary care: A cluster randomized trial

    Annals of Internal Medicine, Vol. 164, Núm. 10, pp. 656-665

  2. Validación de la versión en español de la Columbia-Suicide Severity Rating Scale (Escala Columbia para Evaluar el Riesgo de Suicidio)

    Revista de Psiquiatria y Salud Mental, Vol. 9, Núm. 3, pp. 134-142

2015

  1. A dimensional comparison between delusional disorder, schizophrenia and schizoaffective disorder

    Schizophrenia Research, Vol. 169, Núm. 1-3, pp. 248-254

  2. Neural substrates of cognitive flexibility in cocaine and gambling addictions

    British Journal of Psychiatry, Vol. 207, Núm. 2, pp. 158-164

  3. The risk for major depression conferred by childhood maltreatment is multiplied by BDNF and SERT genetic vulnerability: A replication study

    Journal of Psychiatry and Neuroscience, Vol. 40, Núm. 3, pp. 187-196